Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Plus Therapeutics ( (PSTV) ) just unveiled an announcement.
On January 9, 2026, Plus Therapeutics filed a registration statement that initially omitted 2025 discretionary cash bonus amounts for certain named executive officers, indicating these would be reported once determined. On February 9, 2026, the board’s compensation committee approved those bonuses and the company disclosed updated 2025 and 2024 compensation figures, highlighting a substantial increase in total pay for its chief executive officer and chief financial officer compared with the prior year, while noting the former chief medical officer had no 2025 compensation following his June 11, 2024 departure.
The most recent analyst rating on (PSTV) stock is a Hold with a $0.23 price target. To see the full list of analyst forecasts on Plus Therapeutics stock, see the PSTV Stock Forecast page.
Spark’s Take on PSTV Stock
According to Spark, TipRanks’ AI Analyst, PSTV is a Underperform.
The score is driven primarily by weak financial performance—large ongoing losses, sharply negative free cash flow, and continued funding risk despite low debt. Technicals also weigh on the score with a clear downtrend (price below key moving averages and negative MACD), only partially offset by oversold readings. Valuation support is limited because the company is loss-making (negative P/E) and no dividend yield is provided.
To see Spark’s full report on PSTV stock, click here.
More about Plus Therapeutics
Plus Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing specialized therapies, with its leadership team comprising a president and chief executive officer, a chief financial officer, and previously a chief medical officer. The company operates in a highly regulated environment where executive compensation disclosures are material to investors and other stakeholders.
Average Trading Volume: 10,108,375
Technical Sentiment Signal: Sell
Current Market Cap: $48.37M
See more insights into PSTV stock on TipRanks’ Stock Analysis page.